All Stories

  1. Evaluating the efficacy of different praziquantel treatment regimens using egg and circulating anodic antigen (CAA) detection methods in a Schistosoma mansoni endemic area in northeastern Brazil
  2. Schistosome Infection is Associated with High-Risk Human Papillomavirus Persistence, Together with Altered Cervicovaginal Microbiota
  3. Urogenital Schistosomiasis Is Associated with an Increased Risk of Plasmodium falciparum Infection in Burkina Faso
  4. Anti-phenolic glycolipid antibodies in Mycobacterium bovis infected cattle
  5. Safety and efficacy of praziquantel 40 mg/kg versus 80 mg/kg in preschool-aged children with intestinal schistosomiasis in Uganda: a 2 × 2 factorial, double-blind, placebo-controlled, phase 2 randomised trial
  6. Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study
  7. Detecting Schistosoma infections in endemic countries: a diagnostic accuracy study in rural Madagascar
  8. Identification of a circulating carbohydrate antigen as a highly specific and sensitive target for schistosomiasis serology
  9. T cell responses in repeated controlled human schistosome infection compared to natural exposure
  10. Detection and analysis of Serpin and RP26 specific antibodies for monitoring Schistosoma haematobium transmission
  11. Lower BMI in Tanzanian Adults with Schistosoma mansoni Infection is Not Explained by Differences in Serum Adipocytokine Levels
  12. Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection
  13. Rapid test for Mycobacterium leprae infection: a practical tool for leprosy
  14. Safety and efficacy of praziquantel in pregnant women infected with Schistosoma haematobium in Lambaréné, Gabon – Clinical results from the randomized, single-blinded, controlled freeBILy-Gabon trial
  15. The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial
  16. Schistosome and malaria exposure and urban–rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials
  17. The effect of intermittent preventive treatment for malaria with dihydroartemisinin–piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial
  18. The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial
  19. Proteomic and transcriptomic host biomarkers for detection of pleural tuberculosis
  20. Detecting two Schistosoma circulating antigens – CCA and CAA – in urine and serum to improve diagnosis of human schistosomiasis
  21. Comparative evaluation of plasma biomarkers of Schistosoma haematobium infection in endemic populations from Burkina Faso
  22. Current status of schistosomiasis in school-aged children in Mwanga district, Tanzania: impact of two decades of annual Mass Drug Administration programme
  23. Repeated versus single praziquantel dosing regimen in treatment of female genital schistosomiasis: a phase 2 randomised controlled trial showing no difference in efficacy
  24. Pre-vaccination Schistosoma mansoni and hookworm infections are associated with altered vaccine immune responses: a longitudinal analysis among adolescents living in helminth-endemic islands of Lake Victoria, Uganda
  25. An assessment of gynecological manifestations in women with female genital schistosomiasis with reference to Schistosoma biomarkers, sexually transmitted infections and bacterial vaginosis
  26. Molecular and Serological Surveillance for Mycobacterium leprae and Mycobacterium lepromatosis in Wild Red Squirrels (Sciurus vulgaris) from Scotland and Northern England
  27. Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multipathogen screening in women, including female genital schistosomiasis, human papillomavirus, Trichomonas and H...
  28. Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial
  29. Schistosome infection among pregnant women in the rural highlands of Madagascar: A cross-sectional study calling for public health interventions in vulnerable populations
  30. Flow-S: A Field-Deployable Device with Minimal Hands-On Effort to Concentrate and Quantify Schistosoma Circulating Anodic Antigen (CAA) from Large Urine Volumes
  31. Comparative evaluation of plasma biomarkers ofSchistosoma haematobiuminfection in endemic populations from Burkina Faso
  32. Clinical and Demographic Factors Associated With Kaposi Sarcoma–Associated Herpesvirus Shedding in Saliva or Cervical Secretions in a Cohort of Tanzanian Women
  33. Validation of artificial intelligence-based digital microscopy for automated detection of Schistosoma haematobium eggs in urine in Gabon
  34. Safety and infectivity of female cercariae in Schistosoma-naïve, healthy participants: a controlled human Schistosoma mansoni infection study
  35. Diagnostic performance of host protein signatures as a triage test for active pulmonary TB
  36. The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia
  37. Field-friendly anti-PGL-I serosurvey in children to monitor Mycobacterium leprae transmission in Bihar, India
  38. Development of lateral flow assays to detect host proteins in cattle for improved diagnosis of bovine tuberculosis
  39. Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses
  40. Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB)
  41. Sensitivity and specificity of human point-of-care circulating cathodic antigen (POC-CCA) test in African livestock for rapid diagnosis of schistosomiasis: A Bayesian latent class analysis
  42. Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts
  43. Visual diagnosis of female genital schistosomiasis in Zambian women from hand-held colposcopy: agreement of expert image review and association with clinical symptoms
  44. Identification of CAA as highly specific and sensitive antibody target for acute schistosomiasis diagnostics
  45. Schistosoma mansoniinfection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses
  46. Effects of Schistosoma mansoni and praziquantel treatment on the lower gastrointestinal mucosa: A cohort study in Tanzania
  47. Diagnostic performance of host protein signatures as a triage test for active pulmonary TB
  48. Association of schistosome infection with adiposity in Tanzania
  49. Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial
  50. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19
  51. Subclinical signs of podocyte injury associated with Circulating Anodic Antigen (CAA) in Schistosoma mansoni-infected patients in Brazil
  52. Limited efficacy of repeated praziquantel treatment in Schistosoma mansoni infections as revealed by highly accurate diagnostics, PCR and UCP-LF CAA (RePST trial)
  53. The Presence of Hemoglobin in Cervicovaginal Lavage Is Not Associated With Genital Schistosomiasis in Zambian Women From the BILHIV Study
  54. Schistosoma mansoni Infection Is Associated With Increased Monocytes and Fewer Natural Killer T Cells in the Female Genital Tract
  55. Diagnosis of Schistosomiasis without a Microscope: Evaluating Circulating Antigen (CCA, CAA) and DNA Detection Methods on Banked Samples of a Community-Based Survey from DR Congo
  56. Sensitivity and specificity of human point-of-care circulating cathodic antigen (POC-CCA) test in African livestock for rapid diagnosis of schistosomiasis: a Bayesian latent class analysis
  57. High prevalence of Schistosoma mansoni infection and stunting among school age children in communities along the Albert-Nile, Northern Uganda: A cross sectional study
  58. Sensitive Diagnosis and Post-Treatment Follow-Up of Schistosoma mansoni Infections in Asymptomatic Eritrean Refugees by Circulating Anodic Antigen Detection and Polymerase Chain Reaction
  59. Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis
  60. Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers
  61. CLINICAL PROGRESSION OF LEPROSY IN EURASIAN RED SQUIRRELS (SCIURUS VULGARIS) IN A NATURALLY INFECTED WILD POPULATION
  62. Candidate gene family-based and case-control studies of susceptibility to high Schistosoma mansoni worm burden in African children: a protocol
  63. Quantitative Rapid Test for Detection and Monitoring of Active Pulmonary Tuberculosis in Nonhuman Primates
  64. A cluster randomized controlled trial for assessing POC-CCA test based praziquantel treatment for schistosomiasis control in pregnant women and their young children: study protocol of the freeBILy clinical trial in Madagascar
  65. Minimally invasive sampling to identify leprosy patients with a high bacterial burden in the Union of the Comoros
  66. Excretion patterns of Schistosoma mansoni antigens CCA and CAA by adult male and female worms, using a mouse model and ex vivo parasite cultures
  67. Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study
  68. Detection and Monitoring of Mycobacterium leprae Infection in Nine Banded Armadillos (Dasypus novemcinctus) Using a Quantitative Rapid Test
  69. Rhesus macaques self-curing from a schistosome infection can display complete immunity to challenge
  70. Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results
  71. Accuracy of Two Circulating Antigen Tests for the Diagnosis and Surveillance of Schistosoma mansoni Infection in Low-Endemicity Settings of Côte d’Ivoire
  72. Association of Female Genital Schistosomiasis With the Cervicovaginal Microbiota and Sexually Transmitted Infections in Zambian Women
  73. Potential of antibody test using Schistosoma mansoni recombinant serpin and RP26 to detect light-intensity infections in endemic areas
  74. Association between cervical dysplasia and female genital schistosomiasis diagnosed by genital PCR in Zambian women
  75. Improving the diagnosis and management of acute schistosomiasis with antibody, antigen and molecular techniques: lessons from a cluster of six travellers
  76. Female Genital Schistosomiasis and HIV-1 Incidence in Zambian Women: A Retrospective Cohort Study
  77. A Cluster Randomised Controlled Trial for Assessing POC-CCA Test Based Praziquantel Treatment for Schistosomiasis Control in Pregnant Women and Their Young Children: Study Protocol of the Freebily Clinical Trial in Madagascar
  78. Early diagnosis and follow-up of acute schistosomiasis in a cluster of infected Belgian travellers by detection of antibodies and circulating anodic antigen (CAA): A diagnostic evaluation study
  79. Specificity of the Point-of-Care Urine Strip Test for Schistosoma Circulating Cathodic Antigen (POC-CCA) Tested in Non-Endemic Pregnant Women and Young Children
  80. Association Between Cervical Dysplasia and Female Genital Schistosomiasis Diagnosed by Genital PCR in Zambian Women
  81. Evaluation of microscopy, serology, circulating anodic antigen (CAA), and eosinophil counts for the follow-up of migrants with chronic schistosomiasis: a prospective cohort study
  82. Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis
  83. Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease
  84. Synthetic Phenolic Glycolipids for Application in Diagnostic Tests for Leprosy
  85. Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the ‘POPulation differences in VACcine responses’ (POPVAC) programme
  86. Cervicovaginal bacterial communities in reproductive-aged Tanzanian women withSchistosoma mansoni,Schistosoma haematobium, or without schistosome infection
  87. Prototype multi-biomarker test for point-of-care leprosy diagnostics
  88. The burden of HIV, syphilis and schistosome infection and associated factors among adults in the fishing communities in northwestern Tanzania
  89. Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the ‘POPulation differences in VACcine responses’ (P...
  90. Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the ‘POPulation differences in VACcine responses’ (POPVAC...
  91. Population differences in vaccine responses (POPVAC): scientific rationale and cross-cutting analyses for three linked, randomised controlled trials assessing the role, reversibility and mediators of immu...
  92. Fast and reliable easy-to-use diagnostics for eliminating bilharzia in young children and mothers: An introduction to the freeBILy project
  93. Prospective, observational study to assess the performance of CAA measurement as a diagnostic tool for the detection of Schistosoma haematobium infections in pregnant women and their child in Lambaréné, Gabon: study protocol of the freeBILy clinical tr...
  94. Household Contacts of Leprosy Patients in Endemic Areas Display a Specific Innate Immunity Profile
  95. Genital self-sampling compared with cervicovaginal lavage for the diagnosis of female genital schistosomiasis in Zambian women: The BILHIV study
  96. Circulating Anodic Antigen (CAA): A Highly Sensitive Diagnostic Biomarker to Detect Active Schistosoma Infections—Improvement and Use during SCORE
  97. Nationwide Remapping of Schistosoma mansoni Infection in Rwanda Using Circulating Cathodic Antigen Rapid Test: Taking Steps toward Elimination
  98. Schistosoma haematobium infection is associated with lower serum cholesterol levels and improved lipid profile in overweight/obese individuals
  99. Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis
  100. Genomic Characterization of Mycobacterium leprae to Explore Transmission Patterns Identifies New Subtype in Bangladesh
  101. Plasma Endotoxin Levels Are Not Increased in Schistosoma mansoni–Infected Women without Signs or Symptoms of Hepatosplenic Disease
  102. Associations between schistosomiasis and HIV‐1 acquisition risk in four prospective cohorts: a nested case‐control analysis
  103. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
  104. Antigen-based diagnosis of Schistosoma infection in travellers: a prospective study
  105. Survey of Schistosomiasis in Saint Lucia: Evidence for Interruption of Transmission
  106. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST)
  107. Does Intensive Treatment Select for Praziquantel Resistance in High-Transmission Settings? Parasitological Trends and Treatment Efficacy Within a Cluster-Randomized Trial
  108. Detection of new Mycobacterium leprae subtype in Bangladesh by genomic characterization to explore transmission patterns
  109. A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics
  110. Author Correction: Placental gene expression and antibody levels of mother-neonate pairs reveal an enhanced risk for inflammation in a helminth endemic country
  111. Survey and Diagnostic Challenges after Transmission-Stop: Confirming Elimination of Schistosomiasis haematobium in Morocco
  112. Insufficiency of annual praziquantel treatment to control Schistosoma mansoni infections in adult women: A longitudinal cohort study in rural Tanzania
  113. Schistosomiasis was not associated with higher HIV-1 plasma or genital set point viral loads among HIV seroconverters from four cohort studies
  114. Placental gene expression and antibody levels of mother-neonate pairs reveal an enhanced risk for inflammation in a helminth endemic country
  115. How can schistosome circulating antigen assays be best applied for diagnosing male genital schistosomiasis (MGS): an appraisal using exemplar MGS cases from a longitudinal cohort study among fishermen on the south shoreline of Lake Malawi
  116. Haemostatic changes in urogenital schistosomiasis haematobium: a case-control study in Gabonese schoolchildren
  117. Application of new host biomarker profiles in quantitative point-of-care tests facilitates leprosy diagnosis in the field
  118. HIV-seroconversion among HIV-1 serodiscordant married couples in Tanzania: a cohort study
  119. Detection of humoral immunity to mycobacteria causing leprosy in Eurasian red squirrels (Sciurus vulgaris) using a quantitative rapid test
  120. In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination
  121. Performance of an Ultra-Sensitive Assay Targeting the Circulating Anodic Antigen (CAA) for Detection of Schistosoma mansoni Infection in a Low Endemic Area in Brazil
  122. Effect of high-intensity versus low-intensity praziquantel treatment on HIV disease progression in HIV and Schistosoma mansoni co-infected patients: a randomised controlled trial
  123. Fingerstick test quantifying humoral and cellular biomarkers indicative for M. leprae infection
  124. Schistosomiasis and HIV-1 viral load in HIV-infected outpatients with immunological failure in Tanzania: a case-control study
  125. Katayama Syndrome Without Schistosoma mansoni Eggs
  126. Poly(amidoamine)-coated magnetic particles for enhanced detection ofSchistosomacirculating anodic antigen in endemic urine samples
  127. Altered Cervical Mucosal Gene Expression and Lower Interleukin 15 Levels in Women With Schistosoma haematobium Infection but Not in Women With Schistosoma mansoni Infection
  128. Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia
  129. In-depth proteomic characterization of Schistosoma haematobium: towards the development of new tools for elimination
  130. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) – single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire: a study protocol for an open-label, randomised controlled trial
  131. Refining Diagnosis of Schistosoma haematobium Infections: Antigen and Antibody Detection in Urine
  132. Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania
  133. Gene Expression Differences in Host Response to Schistosoma haematobium Infection
  134. HIV-1 Viral Loads Are Not Elevated in Individuals Co-infected With Schistosoma spp. After Adjustment for Duration of HIV-1 Infection
  135. Effect of high-intensity versus low-intensity praziquantel treatment on HIV disease progression in HIV and Schistosoma mansoni co-infected patients: a randomised controlled trial
  136. Improved diagnosis of active Schistosoma infection in travellers and migrants using the ultra-sensitive in-house lateral flow test for detection of circulating anodic antigen (CAA) in serum
  137. Impact of schistosome infection on long-term HIV/AIDS outcomes
  138. Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter
  139. Decreased Sensitivity of Schistosoma sp. Egg Microscopy in Women and HIV-Infected Individuals
  140. Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi
  141. Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis
  142. Host immunity, nutrition and coinfection alter longitudinal infection patterns of schistosomes in a free ranging African buffalo population
  143. CRP: tell-tale biomarker or common denominator?
  144. Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies
  145. Effects of schistosomiasis on susceptibility to HIV-1 infection and HIV-1 viral load at HIV-1 seroconversion: A nested case-control study
  146. Field-friendly serological tests for determination of M. leprae-specific antibodies
  147. Comparison of novel and standard diagnostic tools for the detection of Schistosoma mekongi infection in Lao People’s Democratic Republic and Cambodia
  148. Longitudinal IP-10 Serum Levels Are Associated with the Course of Disease Activity and Remission in Patients with Rheumatoid Arthritis
  149. THU0042 Longitudinal IP-10 serum levels associate with the course of disease activity and achieving dmard-free sustained remission in rheumatoid arthritis
  150. Selecting accurate post-elimination monitoring tools to prevent reemergence of urogenital schistosomiasis in Morocco: a pilot study
  151. Schistosomiasis and Human Immunodeficiency Virus in Men in Tanzania
  152. Quantitative lateral flow strip assays as User-Friendly Tools To Detect Biomarker Profiles For Leprosy
  153. Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease
  154. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
  155. Effect ofSchistosoma mansoniInfection on Innate and HIV-1-Specific T-Cell Immune Responses in HIV-1-Infected Ugandan Fisher Folk
  156. Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB
  157. Field-Friendly Test for Monitoring Multiple Immune Response Markers during Onset and Treatment of Exacerbated Immunity in Leprosy
  158. Highly Sensitive Laser Scanning of Photon-Upconverting Nanoparticles on a Macroscopic Scale
  159. Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa
  160. Use of lateral flow assays to determine IP-10 and CCL4 levels in pleural effusions and whole blood for TB diagnosis
  161. Saliva and viral infections
  162. Correlation of serum and dried blood spot results for quantitation of Schistosoma circulating anodic antigen: A proof of principle
  163. Schistosoma mansoni and HIV acquisition in fishing communities of Lake Victoria, Uganda: a nested case–control study
  164. Sensitivity and Specificity of a Urine Circulating Anodic Antigen Test for the Diagnosis of Schistosoma haematobium in Low Endemic Settings
  165. Improved sensitivity of the urine CAA lateral-flow assay for diagnosing active Schistosoma infections by using larger sample volumes
  166. Evaluation of banked urine samples for the detection of circulating anodic and cathodic antigens in Schistosoma mekongi and S. japonicum infections: A proof-of-concept study
  167. An ultra-sensitive assay targeting the circulating anodic antigen for the diagnosis of Schistosoma japonicum in a low-endemic area, People's Republic of China
  168. Human Schistosoma haematobium Antifecundity Immunity Is Dependent on Transmission Intensity and Associated With Immunoglobulin G1 to Worm-Derived Antigens
  169. Feasibility of a Lateral Flow Test for Neurocysticercosis Using Novel Up-Converting Nanomaterials and a Lightweight Strip Analyzer
  170. Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels
  171. Field-Evaluation of a New Lateral Flow Assay for Detection of Cellular and Humoral Immunity against Mycobacterium leprae
  172. The use of upconverting phosphors in point-of-care (POC) testing
  173. A robust dry reagent lateral flow assay for diagnosis of active schistosomiasis by detection of Schistosoma circulating anodic antigen
  174. A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study
  175. Improved assay to detect Plasmodium falciparum using an uninterrupted, semi-nested PCR and quantitative lateral flow analysis
  176. Development of a Generic Microfluidic Device for Simultaneous Detection of Antibodies and Nucleic Acids in Oral Fluids
  177. Association of Schistosomiasis and HIV Infection in Tanzania
  178. Detecting viruses by using salivary diagnostics
  179. Lateral Flow Sandwich Assay Utilizing Upconverting Phosphor (UCP) Reporters
  180. Lateral flow assay for simultaneous detection of cellular- and humoral immune responses
  181. A Rapid Test for Quantitative Determination of Infliximab Trough Levels in Blood
  182. An integrated, self-contained microfluidic cassette for isolation, amplification, and detection of nucleic acids
  183. Finger-actuated, self-contained immunoassay cassettes
  184. A timer-actuated immunoassay cassette for detecting molecular markers in oral fluids
  185. Rapid Prototyping of Lateral Flow Assays
  186. A user-friendly, highly sensitive assay to detect the IFN-γ secretion by T cells
  187. Up-Converting Phosphor Technology-Based Lateral Flow Assay for Detection of Schistosoma Circulating Anodic Antigen in Serum
  188. A Microfluidic System for Saliva-Based Detection of Infectious Diseases
  189. Development of a Microfluidic Device for Detection of Pathogens in Oral Samples Using Upconverting Phosphor Technology (UPT)
  190. Evaluation of UPlink-RSV: Prototype Rapid Antigen Test for Detection of Respiratory Syncytial Virus Infection
  191. Rapid Assay Format for Multiplex Detection of Humoral Immune Responses to Infectious Disease Pathogens (HIV, HCV, and TB)
  192. A disposable microfluidic cassette for DNA amplification and detection
  193. Point Detection of Pathogens in Oral Samples
  194. Field distribution on metallic and dielectric nanoparticles observed with a fluorescent near-field optical probe
  195. Infrared up-converting phosphors for bioassays
  196. EFFECTS OF NITROGEN AND PHOSPHORUS AVAILABILITY ON THE EXPRESSION OF THE COCCOLITH-VESICLE V-ATPASE (SUBUNIT C) Of PLEUROCHRYSIS (HAPTOPHYTA)1
  197. An amplification-free hybridization-based DNA assay to detect Streptococcus pneumoniae utilizing the up-converting phosphor technology
  198. Lateral-flow and up-converting phosphor reporters to detect single-stranded nucleic acids in a sandwich-hybridization assay
  199. MOLECULAR CLONING AND EXPRESSION OF THE PROLIFERATING CELL NUCLEAR ANTIGEN GENE FROM THE COCCOLITHOPHORID PLEUROCHRYSIS CARTERAE (HAPTOPHYCEAE)1
  200. Use of Up-Converting Phosphor Reporters in Lateral-Flow Assays to Detect Specific Nucleic Acid Sequences: A Rapid, Sensitive DNA Test to Identify Human Papillomavirus Type 16 Infection
  201. A COCCOLITHOPHORID CALCIFYING VESICLE WITH A VACUOLAR‐TYPE ATPASE PROTON PUMP: CLONING AND IMMUNOLOCALIZATION OF THE V0 SUBUNIT c
  202. Mucins and Molluscan Calcification
  203. Bacterial Mn2+Oxidizing Systems and Multicopper Oxidases: An Overview of Mechanisms and Functions
  204. Stimulation of Mn2+Oxidation inLeptothrix discophoraSS-1 by Cu2+and Sequence Analysis of the Region Flanking the Gene Encoding Putative Multicopper Oxidase MofA
  205. cumA , a Gene Encoding a Multicopper Oxidase, Is Involved in Mn 2+ Oxidation in Pseudomonas putida GB-1
  206. Involvement of genes of two-step protein secretion pathway in the transport of the manganese-oxidizing factor across the outer membrane of Pseudomonas putida strain GB-I
  207. Involvement of genes of two-step protein secretion pathway in the transport of the manganese-oxidizing factor across the outer membrane of Pseudomonas putida strain GB-I
  208. The Cytochrome c Maturation Operon Is Involved in Manganese Oxidation in Pseudomonas putida GB-1
  209. GPA, A CALCIUM-BINDING PROTEIN IN THE COCCOLITHOPHORID EMILIANIA HUXLEYI (PRYMNESIOPHYCEAE)
  210. Partial purification and characterization of manganese-oxidizing factors of Pseudomonas fluorescens GB-1
  211. Identification and molecular analysis of theLeptothrix discophoraSS‐1mofAgene, a gene putatively encoding a manganese‐oxidizing protein with copper domains
  212. Phylogenetic Analysis of the Metal-Oxidizing Bacteria Leptothrix discophora and Sphaerotilus natans Using 16S rDNA Sequencing Data
  213. Enzymatic iron oxidation by Leptothrix discophora: identification of an iron-oxidizing protein
  214. Oxidation of Manganese and Iron by Leptothrix discophora : Use of N,N,N′,N′ -Tetramethyl- p -Phenylenediamine as an Indicator of Metal Oxidation